Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside the checkpoint inhibitor ...
Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targe…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
Nearly 1 in 30 clinical trials were interrupted by funding cuts to the National Institutes of Health, affecting more than 74,000 patients and research into cancer, infectious disease and more, ...
Historically, clinical trials have been primarily conducted at select academic sites and large cancer centers with the infrastructure for clinical research, raising concerns that trials are not as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results